UPDATE 2-Bristol-Myers raises 2018 forecast, some sales disappoint

NEW YORK, April 26 (Reuters) - Bristol-Myers Squibb Co on Thursday significantly raised its full-year earnings forecast even as first-quarter sales of some medicines fell short of expectations and sent shares of the U.S. drugmaker down more than 1 percent.